Back to Cagrilintide
Cagrilintide Dosage Guide
Complete dosing protocol, reconstitution steps, and interactive calculator for Cagrilintide.
Dosing & Reconstitution Guide
In clinical trials, cagrilintide has been dosed at 0.3–4.5 mg weekly. These findings apply only to research settings.
Standard / Gradual Approach
10mg VialstandardPhaseDoseVolume
Weeks 1–20.6 mg18 units
Weeks 3–41.2 mg36 units
Weeks 5–62.4 mg72 units
Weeks 7–16 (Maintenance)4.5 mg135 units
Standard / Gradual Approach
5mg VialstandardPhaseDoseVolume
Weeks 1–20.6 mg36 units
Weeks 3–41.2 mg72 units
Weeks 5–62.4 mg144 units
Weeks 7–16 (Maintenance)4.5 mg270 units
Protocol Summary
Subcutaneous (SQ): Weekly · Dose range 0.25–4.5 mg with gradual titration
Cycle Length: 4–8 weeks typical; reassess before extending
Frequency & Cycling
SubQ Injection
Inject once weekly; cycle continuously with physician monitoring. Adjust dose upward gradually based on GI tolerance and weight response. Often paired with GLP-1 analogues like semaglutide for synergy.
🧪 Quick Start
Vial Size
10 mg
BAC Water
3 mL
Concentration
3300 mcg/unit
Starting Dose
0.6 mg (18 units)
Maintenance Dose
4.5 mg (135 units)
🧮 Dose Calculator
Concentration
33.3
mcg/unit
Draw Volume
15
units (0.150 mL)
For a 500 mcg dose, draw 15 units on a U-100 insulin syringe